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ABSTRACT
Objective: To trace the source of tuberculous infection of patients with CNS tuberculosis.
Material and methods: We analyzed clinical records of 100 patients with tuberculosis affecting the central nervous
system, who presented to Department of Neurology Civil Hospital Karachi,between Jan 2007 To June 2010.
All patients with confirmed diagnosis of CNS tuberculosis, supported by clinical, laboratory, and radiological evidence
were included. Case histories were analyzed and notes were made in each case of past history of tuberculosis, history
of affected family members at that time and in past, and presence or absence of concurrent extra-neural tuberculosis.
All patients with disseminated tuberculosis were investigated for immunocompromised states like HIV. Patients with
positive contact history were divided into those with tuberculosis affected person within their household, those with
their first degree relatives with history of tuberculosis, and those with workmates or other regular contacts with
tuberculosis. Contacts of all these patients were also investigated to find out the new cases amongst them according
to the WHO guidelines. Results were analyzed on SPSS 17.Results: Among the total of 100 patients, male to female
ratio was 1:3 with ages ranging from 8 to 82 years. Mean age was 34. Fifty six people had tuberculosis affecting brain
and 44 had spinal involvement. Thirty five patients had tuberculous meningitis, 13 had tuberculous meningitis with
tuberculomas, and 8 had tuberculomas only. Major complications of tuberculous meningitis, like stroke(60%),
hydrocephalus(40%) and optic neuropathy(1.5%) were seen in 20 patients. One patient had sagittal sinus thrombosis
in addition to tuberculous meningitis. 44 patients had spinal cord involvement, they presents with compressive
myelopathy, (tuberculous abscess &/or prolapsed vertebrae) and/or myelitis. Twelve patients showed involvement of
cervical spine, 16 dorsal spine and 15 had lumbar spine involvement. One patient had disease of dorsolumbar spine.
Neurosurgical procedures were required in those who developed hydrocephalous and epidural spinal cord abcesses.
At the time of presentation, 20 patients had tuberculous infection in extra-neural tissues /organs as well. Four patients
had abdominal tuberculosis, 6 had disseminated tuberculosis, and 10 had pulmonary tuberculosis. Baseline chest
xray was abnormal in 20% of patients (10% with active concurrent pulmonary tuberculosis while other 10% were
asymptomatic. Fourteen patients had history of tuberculosis in past. Six had pulmonary tuberculosis in past but x-ray
evidence of tuberculosis was available in other two, 2 were diagnosed with abdominal tuberculosis, 3 had tuberculous
lymph adenitis, and one patient was diagnosed as tuberculous meningitis. Twenty six percent of patients could trace
the source of infection among their relatives, while majority (74%) did not give history of any affected family member,
relative or contact, at that time or in past. Fourteen percent had an affected household (parent, sibling), and 12%
gave history of an affected first degree relative. Conclusion: Tracing the source of infection with clinical methods alone
was not very much beneficial. We need advance strategies to supplement our clinical methods to find out the source
of transmission of this illness and to eradicate and manage effectively the spread of infection in our community.
malnutrition and a compromised immune system play
a major role in emergence of 80% of new tuberculosis
cases worldwide3. Pakistan ranks 8th amongst the high
burden TB countries in the world and harbor 63% of
tuberculosis burden in the Eastern Mediterranean Region
of WHO4. Every year 420,000 new Tuberculosis cases
emerge and 69,000 people die from Tuberculosis in
Pakistan4.According to the WHO the incidence and

INTRODUCTION
Tuberculosis remains a worldwide burden, with a large
majority of new active tuberculosis cases occurring in
underdeveloped and developing countries1.The annual
number of new cases of TB has continued to grow all
over the world reaching 9.4 million in
20092.Demographic factors such as poverty, crowding,

PAKISTAN

JOURNAL

OF

NEUROLOGICAL

SCIENCES

15

VOL.

8(4) OCT - DEC

2013

prevalence of TB in Pakistan is 230 per 100,000and
310 per 100,000 respectively5.

with workmates or other regular contacts with
tuberculosis. Results were analyzed on SPSS 17.
RESULTS

CNS tuberculosis represents one of the most severe
forms of extra pulmonary tuberculosis. 6.3% of extra
pulmonary cases (1.3% of total tuberculosis cases)
involve the CNS.6Diagnosis of CNS Tuberculosis requires
a high index of suspicion, thorough contact tracing,
and appropriate investigations with early treatment to
reduce morbidity and mortality.Despite treatment,
mortality and long-term disability remain high.
Although a lot of local and international research has
been done regarding different aspects of CNS
tuberculosis, fundamental questions regarding the
source of the infection of the index case remain
unanswered. Source tracing is the key ofbetter
managementand eradication of every communicable
disease. In our study we try to find out clinically the
cause of this devastating illness through contact tracing.

Among the total of 100 patients, 24 were males and
76 were females (male to female ratio 1:3) with ages
ranging from 8 to 82 years with a mean age of 34
years. Maximum number of patients belonged to age
group 21-40 years which had 48 patients. Age group
20 years had 35 patients (out of these 25 were
vaccinated with BCG while 10 were not vaccinated);
11 patients were in age group 41-60 years and 6
patients wereover 60 years of age.
Fifty six people had tuberculosis affecting brain and 44
had spinal involvement.
Thirty five patients had tuberculous meningitis, 13 had
tuberculous meningitis with tuberculomas, and 8 had
tuberculomas only. Mycobacterium tuberculosis was
cultured in 18 % whileidentified by PCR in cerebrospinal
fluid of other 20% patients.Major complications of
tuberculous meningitis, like stroke (12), hydrocephalus
(8) and optic neuropathy (3) were seen in 20 (57% of
brain infection)patients. Two patients had both stroke
and hydrocephalus and one patient had simultaneous
optic neuropathy and hydrocephalus. One patient had
sagittal sinus thrombosis in addition to tuberculous
meningitis. Stroke, due to both small and middle vessel
vasculitis, was seen in 12 patients with meningitis and
7 patients had meningitis, tuberculomas and stroke.
44 patients had spinal involvement withcompressive
myelopathy, (tuberculous abscess &/or prolapsed
vertebrae) and/or myelitis. Twelve patients showed
involvement of cervical spine, 16 dorsal spine and 15
had lumbar spine involvement. One patient had disease
of dorsolumbar spine.

MATERIALS AND METHOD
We analyzed completed records of 100 consecutive
patients with tuberculosis affecting the central nervous
system, who presented to Department of Neurology
Civil Hospital Karachi, to trace the source of infection
in each patient. These included patients with tuberculous
meningitis (TBM), tuberculomas of brain and spinal
cord, Pott's disease with compressive myelopathy and
tuberculous myelitis.
These patients presented to our department between
Jan 2007 To June 2010. We did not include records
of those patients which were incomplete, or those
patients who left against medical advice before
completion of investigations.
All patients with confirmed diagnosis of tuberculosis,
supported by clinical, laboratory, and radiological
evidence were included. Case histories were analyzed
and notes were made in each case of past history of
tuberculosis, history of affected family members at that
time and in past, and presence or absence of concurrent
extra-neural tuberculosis. All patients with disseminated
tuberculosis were investigated for immunocompromised
states like HIV. Contacts of all these index patients
were also investigated to find out the new cases amongst
them according to the WHO guidelines.

Chest x-ray was abnormal in 20 patients. Ten of them
had concurrent active pulmonary tuberculosis, while
remaining 10 were asymptomatic.
Only 14 patients had history of tuberculosis in past.
Six had pulmonary tuberculosis in past but x-ray evidence
of tuberculosis was available in other two, 2 were
diagnosed with abdominal tuberculosis, 3 had
tuberculous lymph adenitis, and one patient was
diagnosed as tuberculous meningitis. Thepatient, who
was diagnosed with tuberculous meningitis 7 years
back, took treatment for 6 months only (while our
current practice is to treat patients with tuberculous
nervous system disease for duration of 18 to 24
months). All other patient reportedly continued treatment
and completed therapy for prescribed duration. However,

Patients with positive contact history were divided into
those with tuberculosis affected person within their
household (parents, sibs, husband, wife or children),
those with their first degree relatives with history of
tuberculosis (uncles, aunt, grandparents), and those
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Only 26 patients could trace the source of infection
among their contacts, while majority (74) did not give
history of any affected family member, relative or regular
contact, at that time or in past. 14 patients had contact
with their house holds (6 had an affected parent, 8
had affected sibling),12 gave history of an affected first
degree relative, while none gave the history of affected
workmate or other regular contacts. None of these
contacts had active tuberculosis at that time. Except
for the two all these contacts were treated and not
currentlytaking anti-tuberculous therapy. All ofthem
were alsocompliant withthe treatment.

grade II and grade III with positive chest radiographic
findings.10 In our study we found chest x-ray abnormalities
in 20% of patients. 10 of them had active pulmonary
tuberculosis while remaining 10 were asymptomatic.
Another study suggests that the presence of active
pulmonary tuberculosis on chest X ray may rangesfrom
30 to 50%11.
According to the WHO in 2011 there were 270394 no
of notified tuberculosis and 344 no ofnotified MDR TB
cases in Pakistan.12In view of the MDR tuberculosis, it
is essential to isolate M. tuberculosis and determine
its sensitivity at the outset. In our study routine CSF
culture was positive in only 18% of patients while PCR
identified the Mycobacterial DNA in 20%others. As we
were unable to isolate the bacteria in all patients we
were not able to document the trend of drug resistant
in our patients. In such cases we followed clinical and
radiological response to the standard treatment, and
added second line therapy if no response was seen
after 6-8 weeks.

At the time of presentation, 20 patients were found to
be harboring tuberculous infection in extra-neural
tissues /organs as well during investigations for
tuberculosis of the nervous system. Four patients had
abdominal tuberculosis, 6 had disseminated tuberculosis,
and 10 had pulmonary tuberculosis.
Anti-tuberculous therapy was given according to the
standard 18 to 24 months; concurrent steroids were
given to all patients with tuberculous meningitis with
or without tuberculomas, tuberculomas alone and
myelitis. Neurosurgical procedures were required in
those who developed hydrocephalous and epidural
spinal cord abcesses, these were 23 patients. Follow
up imaging done during treatment where clinically
indicated and at the end of therapy.

International literature showed that approximately 10%
of patients with CNS tuberculosis gave the history of
tuberculosis in past11. In our study only 14% of patients
gave the past history of tuberculosis and 26% patients
could trace the contact with tuberculosis patients in
the past. These observations were exactly similar to
the recently published local data.7This shows that on
the basis of clinical history alone we were unable to
trace the source of infection of this illness. To evaluate
the various transmission routes of tuberculosis,National
Tuberculosis Control Program should develop an effective
method for contacts' investigations.

DISCUSSION
This is a prospective case series of 100 patients with
central nervous system tuberculosis presented at tertiary
care hospital during the period of Jan 2007 - June
2010.Mean age of presentation wasthe same as
compare to otherlocaldata.7 In our study male to female
ratio was 1:3(24 were males and 76 were females).
This gender distribution was different as compare to
the recently published local data7 while similar to other
studies.8 Almost all of our patients belonged to the low
socioeconomic group. Majority of women had poor
nutritional status (guided by the body mass index
calculated at the time of initiation of therapy). Begum
et al studied the reasons of female disease
preponderance and find out that women havepoorer
nutritional status than their male counterparts and
socialstigma associated with TB discourages women
fromseeking early medical care.9

had concurrent active pulmonary tuberculosis, while
remaining 10 were asymptomatic.
Only 14 patients had history of tuberculosis in past.
Six had pulmonary tuberculosis in past but x-ray evidence
of tuberculosis was available in other two, 2 were
diagnosed with abdominal tuberculosis, 3 had
tuberculous lymph adenitis, and one patient was
diagnosed as tuberculous meningitis. Thepatient, who
was diagnosed with tuberculous meningitis 7 years
back, took treatment for 6 months only (while our
current practice is to treat patients with tuberculous
nervous system disease for duration of 18 to 24
months). All other patient reportedly continued treatment
and completed therapy for prescribed duration. However,
record was available in only these 14 patients. Eighty
six patients were never diagnosed with tuberculosis.
Only 26 patients could trace the source of infection
among their contacts, while majority (74) did not give

Patients with neurotuberculosis may have chest
radiographic evidence of pulmonary TB even in the
absence of pulmonary signs and symptoms at
presentation. There is a strong association of clinical
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history of any affected family member, relative or regular
contact, at that time or in past. 14 patients had contact
with their house holds (6 had an affected parent, 8
had affected sibling),12 gave history of an affected first
degree relative, while none gave the history of affected
workmate or other regular contacts. None of these
contacts had active tuberculosis at that time. Except
for the two all these contacts were treated and not
currentlytaking anti-tuberculous therapy. All ofthem
were alsocompliant withthe treatment.

tuberculosis while remaining 10 were asymptomatic.
Another study suggests that the presence of active
pulmonary tuberculosis on chest X ray may rangesfrom
30 to 50%11.
According to the WHO in 2011 there were 270394 no
of notified tuberculosis and 344 no ofnotified MDR TB
cases in Pakistan.12In view of the MDR tuberculosis, it
is essential to isolate M. tuberculosis and determine
its sensitivity at the outset. In our study routine CSF
culture was positive in only 18% of patients while PCR
identified the Mycobacterial DNA in 20%others. As we
were unable to isolate the bacteria in all patients we
were not able to document the trend of drug resistant
in our patients. In such cases we followed clinical and
radiological response to the standard treatment, and
added second line therapy if no response was seen
after 6-8 weeks.

At the time of presentation, 20 patients were found to
be harboring tuberculous infection in extra-neural
tissues /organs as well during investigations for
tuberculosis of the nervous system. Four patients had
abdominal tuberculosis, 6 had disseminated tuberculosis,
and 10 had pulmonary tuberculosis.
Anti-tuberculous therapy was given according to the
standard 18 to 24 months; concurrent steroids were
given to all patients with tuberculous meningitis with
or without tuberculomas, tuberculomas alone and
myelitis. Neurosurgical procedures were required in
those who developed hydrocephalous and epidural
spinal cord abcesses, these were 23 patients. Follow
up imaging done during treatment where clinically
indicated and at the end of therapy.

International literature showed that approximately 10%
of patients with CNS tuberculosis gave the history of
tuberculosis in past11. In our study only 14% of patients
gave the past history of tuberculosis and 26% patients
could trace the contact with tuberculosis patients in
the past. These observations were exactly similar to
the recently published local data.7This shows that on
the basis of clinical history alone we were unable to
trace the source of infection of this illness. To evaluate
the various transmission routes of tuberculosis,National
Tuberculosis Control Program should develop an effective
method for contacts' investigations.

DISCUSSION
This is a prospective case series of 100 patients with
central nervous system tuberculosis presented at tertiary
care hospital during the period of Jan 2007 - June
2010.Mean age of presentation wasthe same as
compare to otherlocaldata.7 In our study male to female
ratio was 1:3(24 were males and 76 were females).
This gender distribution was different as compare to
the recently published local data7 while similar to other
studies.8 Almost all of our patients belonged to the low
socioeconomic group. Majority of women had poor
nutritional status (guided by the body mass index
calculated at the time of initiation of therapy). Begum
et al studied the reasons of female disease
preponderance and find out that women havepoorer
nutritional status than their male counterparts and
socialstigma associated with TB discourages women
fromseeking early medical care.9

Modern DNA analysis proved to be a very effective tool
to better target and evaluate TB control interventions
in developed countries.It providesinsights into the
process of tuberculosis transmission, which may
otherwise go unrecognized by conventional contact
investigations. Additionally, it plays an important role
in identifying places of tuberculosis outbreaks. A
Japanese study reviewed the records of 21 tuberculosis
patients involved in an outbreak of tuberculosis; the
records were collected by conventional epidemiological
studies. Mycobacterium tuberculosis isolates were
genotyped using IS6110-based restriction fragment
length polymorphism (RFLP).They conclude that RFLP
surveillance forms the bridge between conventional
contact investigation and targeted active case
finding.13Another large-scale tuberculosis investigation
was conducted in Harlingen in 1993 when a 2.5 year
old patient with tuberculous meningitis was reported.
Source tracing and contact tracing was extended from
Harlingen to the west of the Netherlands and even
abroad. Modern DNA analysis (RFLP) was used to map
the tuberculosis transmission. A total of 6519 persons

Patients with neurotuberculosis may have chest
radiographic evidence of pulmonary TB even in the
absence of pulmonary signs and symptoms at
presentation. There is a strong association of clinical
grade II and grade III with positive chest radiographic
findings.10 In our study we found chest x-ray abnormalities
in 20% of patients. 10 of them had active pulmonary
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were screened and 276 infected people were identified,
of whom 49 were suffering from active tuberculosis.
RFLP analysis showed in 27 of them a 'Harlingen' type
Mycobacterium tuberculosis DNA pattern identical to
that of the index patient. The source patient was finally
traced in England14.

In our study 35 patients belonged to the age 20
years (out of these 25 were vaccinated with BCG while
10 were not vaccinated). We found difference in terms
of severity of clinical presentation between vaccinated
and unvaccinated group (vaccinated grade I and II vs.
nonvaccinated grade II and III). This observation was
contradictory to previously published local data21.

Although wegave shortcourse of steroidsto all patients
with tuberculous meningitis, tuberculomas, and myelitis,
still 20% developed complications like hydrocephalous
(40%), stroke (60%) and optic neuritis (1.5%).As we
did not randomized the patients in two groups (steroid
treatment vs placebo), we were unable to postulate
the effects of steroids in improving disability or survival.
Looking at the impact of dexamethasone on
hydrocephalus and infarction, Schoeman et al. reported
that steroids did not appear to affect intracranial pressure
or the extent of infarction in children despite having a
positive influence on survival.15Thwaites et al. used
serial MRI to assess the effect of dexamethasone on
hydrocephalus, basal meningeal enhancement, the
presence of tuberculoma, and infarction, and they were
unable to demonstrate that dexamethasone influenced
any of these parameters as well,16while some other
studies have shown that corticosteroids improved both
survival rate and neurological outcome in patients with
tuberculous meningitis.17

CONCLUSION
CNS tuberculosis is a devastating illness.Clinical methods
alone are not helpful to trace the source of infection
and to find out the active cases amongst contacts. For
finding out the potential sources of infection and thus
better eradication of disease we need to supplement
our clinical methods with modern DNA analysis
techniques. Mass screening programs for the screening
of cured and contacts of under treatment index cases
should be launched.
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Among smokers 11/37, five (45% among smokers)
had raised homocysteine more than 15 umol/lit showing
that not all smokers have raised Homocysteine above
critical levels. On the other hand five of nineteen patients
with raised Homocysteine were smokers which come
out to be 26.3%. In comparison, among nineteen
patients with raised Homocysteine fourteen 78.94%
were either nonsmokers or had quit smoking more than
five years back.

7.

8.

9.

It is evident from our study that raised Homocysteine
levels are commonly found in patients of ischemic
stroke and every other patient is having raised level
which is more frequent than published in international
studies. This finding is also independent of smoking
status and gender of the patients. Either this finding
can be generalized for population at large, needs further
community based study. We recommend regular
investigation in all patients of ischemic stroke and Folic
acid and Vit. B 12 should be given as a routine in
ischemic stroke patient considering high prevalence of
raised Homocysteine as giving B12, Folic acid and
Pyridoxine has shown reduction in stroke incidence in
international literature (25). Bushnell CD and colleagues
reported in their study a threshold of 14.5 umol/Lit of
Homocysteine to treat the patient 26.
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11.
12.
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